Regionally Distinct Alterations in the Composition of the Gut Microbiota in Rats with Streptozotocin-Induced Diabetes
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
The aim of this study was to map the microbiota distribution along the gut and establish whether colon/faecal samples from diabetic rats adequately reflect the diabetic alterations in the microbiome. Streptozotocin-treated rats were used to model type 1 diabetes mellitus (T1D). Segments of the duodenum, ileum and colon were dissected, and the microbiome of the lumen material was analysed by using next-generation DNA sequencing, from phylum to genus level. The intestinal luminal contents were compared between diabetic, insulin-treated diabetic and healthy control rats. No significant differences in bacterial composition were found in the luminal contents from the duodenum of the experimental animal groups, whereas distinct patterns were seen in the ileum and colon, depending on the history of the luminal samples. Ileal samples from diabetic rats exhibited particularly striking alterations, while the richness and diversity obscured some of the modifications in the colon. Characteristic rearrangements in microbiome composition and diversity were detected after insulin treatment, though the normal gut flora was not restored. The Proteobacteria displayed more pronounced shifts than those of the predominant phyla (Firmicutes and Bacteroidetes) in the rat model of T1D. Diabetes and insulin replacement affect the composition of the gut microbiota in different, gut region-specific manners. The luminal samples from the ileum appear more suitable for diagnostic purposes than the colon/faeces. The Proteobacteria should be at the focus of diagnosis and potential therapy. Klebsiella are recommended as biomarkers of T1D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The epithelial barrier dysfunction may be triggered by the presence of some microbial communities and their derived metabolites [270,271], which can be assessed by circulating zonulin as well as by circulating LPS.”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [271]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Richness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413 · cited 1×
“Recent studies suggest that there might be an inflammation-triggering effect of the intestinal microbiota in the development of autoimmune diabetes [2–5].”
BackgroundGut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182 · cited 1×
“It is noteworthy that a close relative from the same family, the pathogenic Escherichia coli, has been identified as the main culprit in various GI tract diseases, including autoimmune diabetes, in humans [43–48].”
BackgroundThe NIH Human Microbiome Project
The NIH HMP Working Group, Peterson, J., Garges, S., Giovanni, M., McInnes, P., Wang, L., Schloss, J. A., Bonazzi, V., McEwen, J. E., Wetterstrand, K. A., et al. (2009) · Genome Research · doi:10.1101/gr.096651.109 · Cited by 2,066
Microbial Influences in Inflammatory Bowel Diseases
Sartor, R. B. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.059 · Cited by 1,927
Microbes in Gastrointestinal Health and Disease
Neish, A. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.080 · Cited by 1,386
Zoetendal, E. G., von Wright, A., Vilpponen-Salmela, T., Ben-Amor, K., Akkermans, A. D. L., & de Vos, W. M. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.7.3401-3407.2002 · Cited by 868 · cited 2×
“The underlying assumption that all microbes thriving in the gut are equally represented in the stools is at best only partially correct [23–27].”
BackgroundArchaea and fungi of the human gut microbiome: correlations with diet and bacterial residents
Hoffmann, C., Dollive, S., Grunberg, S., Chen, J., Li, H., Wu, G. D., Lewis, J. D., & Bushman, F. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066019 · Cited by 808 · cited 1×
“The microbiome of the gut has been extensively studied, particularly in humans, during the past few years, including major metagenomic projects in the USA [16–19] and Europe [20–22].”
BackgroundToward defining the autoimmune microbiome for type 1 diabetes
Giongo, A., Gano, K. A., Crabb, D. B., Mukherjee, N., Novelo, L. L., Casella, G., Drew, J. C., Ilonen, J., Knip, M., Hyöty, H., et al. (2011) · The ISME Journal · doi:10.1038/ismej.2010.92 · Cited by 806
Gut microbiome-host interactions in health and disease
Kinross, J. M., Darzi, A. W., & Nicholson, J. K. (2011) · Genome Medicine · doi:10.1186/gm228 · Cited by 691
High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota
Zoetendal, E. G., Rajilić-Stojanović, M., & de Vos, W. M. (2008) · Gut · doi:10.1136/gut.2007.133603 · Cited by 673
Bytzer, P., Talley, N. J., Leemon, M., Young, L. J., Jones, M. P., & Horowitz, M. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.16.1989 · Cited by 632 · cited 1×
“T1D is frequently associated with a variety of gastrointestinal (GI) motility abnormalities in which selective nitrergic myenteric neuropathy has been well documented both in humans [7–9] and in rodent models [10–12].”
BackgroundThe “Perfect Storm” for Type 1 Diabetes
Vaarala, O., Atkinson, M. A., & Neu, J. (2008) · Diabetes · doi:10.2337/db08-0331 · Cited by 497
Willing, B., Halfvarson, J., Dicksved, J., Rosenquist, M., Järnerot, G., Engstrand, L., Tysk, C., & Jansson, J. K. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20783 · Cited by 455
Bacterial Community Mapping of the Mouse Gastrointestinal Tract
Gu, S., Chen, D., Zhang, J.-N., Lv, X., Wang, K., Duan, L.-P., Nie, Y., & Wu, X.-L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074957 · Cited by 443
Imbalance in the composition of the duodenal microbiota of children with coeliac disease
Nadal, I., Donant, E., Ribes-Koninckx, C., Calabuig, M., & Sanz, Y. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47410-0 · Cited by 396
Wirth, R., Kovács, E., Maróti, G., Bagi, Z., Rákhely, G., & Kovács, K. L. (2012) · Biotechnology for Biofuels · doi:10.1186/1754-6834-5-41 · Cited by 380
Self-citationA metagenomic insight into our gut's microbiome
Lepage, P., Leclerc, M. C., Joossens, M., Mondot, S., Blottière, H. M., Raes, J., Ehrlich, D., & Doré, J. (2013) · Gut · doi:10.1136/gutjnl-2011-301805 · Cited by 370
Brugman, S., Klatter, F. A., Visser, J. T. J., Wildeboer-Veloo, A. C. M., Harmsen, H. J. M., Rozing, J., & Bos, N. A. (2006) · Diabetologia · doi:10.1007/s00125-006-0334-0 · Cited by 332
Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria
Macpherson, A. J., Geuking, M. B., & McCoy, K. D. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02159.x · Cited by 283
Lactobacillus johnsonii N6.2 Mitigates the Development of Type 1 Diabetes in BB-DP Rats
Valladares, R., Sankar, D., Li, N., Williams, E., Lai, K.-K., Abdelgeliel, A. S., Gonzalez, C. F., Wasserfall, C. H., Larkin, J., Schatz, D., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010507 · Cited by 279
Lepage, P., Seksik, P., Sutren, M., de la Cochetière, M.-F., Jian, R., Marteau, P., & Doré, J. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000159662.62651.06 · Cited by 270
Gut microbiota: next frontier in understanding human health and development of biotherapeutics
Prakash, S., Rodes, L., Coussa-Charley, M., Tomaro-Duchesneau, C., Tomaro-Duchesneau, C., Coussa-Charley, & Rodes (2011) · Biologics: Targets and Therapy · doi:10.2147/btt.s19099 · Cited by 256
Roesch, L. F. W., Lorca, G. L., Casella, G., Giongo, A., Naranjo, A., Pionzio, A. M., Li, N., Mai, V., Wasserfall, C. H., Schatz, D., et al. (2009) · The ISME Journal · doi:10.1038/ismej.2009.5 · Cited by 242
How Does Type 1 Diabetes Develop?
Atkinson, M. A., Bluestone, J. A., Eisenbarth, G. S., Hebrok, M., Herold, K. C., Accili, D., Pietropaolo, M., Arvan, P. R., Von Herrath, M., Markel, D. S., et al. (2011) · Diabetes · doi:10.2337/db10-1797 · Cited by 232
A fundamental bimodal role for neuropeptide Y1 receptor in the immune system
Wheway, J., Mackay, C. R., Newton, R. A., Sainsbury, A., Boey, D., Herzog, H., & Mackay, F. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051971 · Cited by 194
Inhibition of Type 1 Diabetes Correlated to a Lactobacillus johnsonii N6.2-Mediated Th17 Bias
Lau, K., Benitez, P., Ardissone, A., Wilson, T. D., Collins, E. L., Lorca, G., Li, N., Sankar, D., Wasserfall, C., Neu, J., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001864 · Cited by 158
King, C., & Sarvetnick, N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017049 · Cited by 150
Vaarala, O., Ilonen, J., Ruohtula, T., Pesola, J., Virtanen, S. M., Härkönen, T., Koski, M., Kallioinen, H., Tossavainen, O., Poussa, T., et al. (2012) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2011.1559 · Cited by 127 · cited 1×
“The mucosal inflammation results in a leaky epithelium; this allows the easier passage of bacteria through the intestinal epithelium, initiating a pathological cascade disturbing the intestinal immunology, a critical element in the development of the autoimmune T1D [40–42].”
BackgroundMarietta, E. V., Gomez, A. M., Yeoman, C., Tilahun, A. Y., Clark, C. R., Luckey, D. H., Murray, J. A., White, B. A., Kudva, Y. C., & Rajagopalan, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078687 · Cited by 124
Type 1 diabetes: role of intestinal microbiome in humans and mice
Boerner, B. P., & Sarvetnick, N. E. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06340.x · Cited by 107
Human Intestinal Microbiota and Type 1 Diabetes
Vaarala, O. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0409-5 · Cited by 94
Upper gastrointestinal microbiota and digestive diseases
Wang, Z.-K. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i10.1541 · Cited by 88
Gutiérrez‐Cañas, I., Juarranz, Y., Santiago, B., Arranz, A., Martínez, C., Galindo-Izquierdo, M., Payá, M., Gomariz, R. P., & Pablos, J. L. (2005) · Rheumatology · doi:10.1093/rheumatology/kei219 · Cited by 86
Krause, D. O., Little, A. C., Dowd, S. E., & Bernstein, C. N. (2010) · Journal of Bacteriology · doi:10.1128/jb.01290-10 · Cited by 84
Izbéki, F., Wittmann, T., Rosztoczy, A. I., Linke, N., Bódi, N., Fekete, É., & Bagyánszki, M. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.12.013 · Cited by 78
Self-citationSchoster, A., Arroyo, L. G., Staempfli, H. R., & Weese, J. S. (2013) · BMC Research Notes · doi:10.1186/1756-0500-6-91 · Cited by 71
Cellular pathogenesis of diabetic gastroenteropathy.
Ördög, T., Hayashi, Y., & Gibbons, S. J. (2009) · PubMed · Cited by 70
Ugarte, M., Brown, M., Hollywood, K. A., Cooper, G. J. S., Bishop, P. N., & Dunn, W. B. (2012) · Genome Medicine · doi:10.1186/gm334 · Cited by 68
Hänninen, A. L. M., Nurmela, R., Maksimow, M., Heino, J., Jalkanen, S., & Kurts, C. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060142 · Cited by 61
Rosztoczy, A. I., Róka, R., Várkonyi, T. T., Lengyel, C., Izbéki, F., Lonovics, J., & Wittmann, T. (2004) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2004-813618 · Cited by 43
Demedts, I., Masaoka, T., Kindt, S., Hertogh, G. D., Geboes, K., Farré, R., Berghe, P. V., & Tack, J. (2013) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2013.19.2.161 · Cited by 43
Vasseur, M. V., Laurentie, M., Rolland, J.-G., Perrin‐Guyomard, A., Henri, J., Ferran, A. A., Toutain, P., & Bousquet‐mélou, A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02135-13 · Cited by 41
Gut Region‐Specific Diabetic Damage to the Capillary Endothelium Adjacent to the Myenteric Plexus
BÓDI, N., TALAPKA, P., POLES, M. Z., HERMESZ, E., JANCSÓ, Z., KATAROVA, Z., IZBÉKI, F., WITTMANN, T., FEKETE, É., & BAGYÁNSZKI, M. (2012) · Microcirculation · doi:10.1111/j.1549-8719.2012.00164.x · Cited by 35
Self-citationRole of Klebsiella and collagens in Crohnʼs disease: a new prospect in the use of low-starch diet
Rashid, T., Ebringer, A., Tiwana, H., & Fielder, M. D. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328318ecde · Cited by 21
Almirón, M. A., Traglia, G. M., Rubio, A., & Sanjuan, N. A. (2013) · Current Microbiology · doi:10.1007/s00284-013-0367-9 · Cited by 16
Research works printed but not linked: 2
- AS Neish, 2009, Microbes in gastrointestinal health and disease, Gastroenterol, 136, 65, 10.1053/j.gastro.2008.10.080 · DOI · Paper page
- DO Krause, 2011, Genome announcements, J Bacteriol, 193, 583
Cited by
Bauer, P. V., Duca, F. A., Waise, T. M. Z., Rasmussen, B. A., Abraham, M. A., Dranse, H. J., Puri, A., O’Brien, C. A., & Lam, T. K. T. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.09.019 · Cited by 265
Kohl, K. D., Brun, A., Magallanes, M., Brinkerhoff, J., Laspiur, A., Acosta, J. C., Caviedes‐Vidal, E., & Bordenstein, S. R. (2017) · Molecular Ecology · doi:10.1111/mec.13921 · Cited by 250
Harnessing Gut Microbes for Mental Health: Getting From Here to There
Bruce-Keller, A. J., Salbaum, J. M., & Berthoud, H.-R. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.08.014 · Cited by 189
Tian, L., Scholte, J., Borewicz, K., van den Bogert, B., Smidt, H., Scheurink, A. J. W., Gruppen, H., & Schols, H. A. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600149 · Cited by 170
Pellegrini, S., Sordi, V., Bolla, A. M., Saita, D., Ferrarese, R., Canducci, F., Clementi, M., Invernizzi, F., Mariani, A., Bonfanti, R., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3222 · Cited by 152
Metadata
- Authors
- Wirth, R., Bódi, N., Maróti, G., Bagyánszki, M., Talapka, P., Fekete, É., Bagi, Z., & Kovács, K. L.
- Affiliations
- University of Szeged (HU)
- HUN-REN Szegedi Biológiai Kutatóközpont (HU)
- Corresponding author
- Kovács, Kornél L.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-12-03
- Volume
- 9
- Issue
- 12
- Pages
- e110440
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4254516
- OpenAlex
- W2158214685
- Cited by
- 69
- References
- 49
- Citations by year
- 2026: 3 · 2024: 3 · 2023: 9 · 2022: 6 · 2021: 7 · 2020: 7 · 2019: 6 · 2018: 7 · 2017: 8 · 2016: 7 · 2015: 5
- FWCI
- 2.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- SZTE Publicatio Repozitórium (University of Szeged) (acceptedVersion, other-oa)
- Repository of the Academy's Library (Library of the Hungarian Academy of Sciences) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- European Commission (-2012-0001, A/2-11-1-2012-0001, 4.2.4.A/2-11-1-2012-0001, 2010-0012)
- Hungarian Scientific Research Fund (A/2-11-1-2012-0001, PD 108309, -2012-0001)
- Magyar Tudományos Akadémia (-2012-0001, A/2-11-1-2012-0001)
- European Social Fund (A/2–11/1-2012-0001, 4.2.4.A/2-11-1-2012-0001, -2012-0001)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- gut microbiota, type 1 diabetes, streptozotocin-induced diabetes, duodenum, ileum, colon, luminal contents, insulin therapy, Proteobacteria, Klebsiella, biomarkers, microbiome diversity, rat model
- MeSH terms
- Animals, Bacteria, Colon, Diabetes Mellitus, Experimental, DNA, Bacterial, Feces, Ileum, Klebsiella, Male, Streptozocin, Rats, Wistar, Sequence Analysis, DNA, Proteobacteria, Rats, High-Throughput Nucleotide Sequencing, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.